526075-BOM

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Rekvina Laboratories Ltd.

BSE: 526075

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

25.27-1.3 (-5.00%)

24 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

15.23

P/E (TTM)

P/B

P/S (TTM)

EV/EBITDA

CAPE (5Y)

ROE (TTM)

ROCE (TTM)

ROA (TTM)

Avg 3Y ROE

Earnings 3Y CAGR

Sales 3Y CAGR

Sales 5Y CAGR

Debt/Equity

Consensus TP

Strong Buy %

Promoter Holding

41.30

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Rekvina Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Rekvina Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Not enough data

Profit After Tax FY

Not enough data

ROE FY

Not enough data

EBITDA FY

Not enough data

Rekvina Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Rekvina Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	45.09	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30
Indian Promoter	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	45.09	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30	41.30
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	54.91	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70	58.70
Bodies Corporate	4.82	4.82	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	4.83	5.26	4.82	4.82	4.82	8.31	6.44	6.44	6.44	6.48	6.49
Others (incl. Retail) No. of shareholders	53.88 2,421	53.88 2,421	53.87 2,420	53.87 2,420	53.87 2,422	53.87 2,421	53.87 2,426	53.87 2,428	53.87 2,428	53.87 2,428	53.87 2,428	53.87 2,428	53.87 2,428	53.87 2,428	53.87 2,428	53.87 2,428	49.65 2,215	53.88 2,420	53.88 2,437	53.88 2,419	50.39 2,416	52.26 2,435	52.26 2,417	52.26 497	52.22 2,462	52.21 2,454

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Rekvina Laboratories Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Priyanka Jain	20 Feb 2026	buy	₹ 23.63	36.01 k	-

Corporate Actions

History of Rekvina Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Stock Split1 : 2
Ex-date: 30th Apr 2014Announced on: 22nd Mar 2014
Nominal value changes from INR 10 to INR 5 for each share held.

Company Profile

Overview of Rekvina Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Rekvina Laboratories Limited is an India-based company. The Company is engaged in the manufacturing and marketing of pharmaceutical products. The Company operates through a single segment, namely Trading of Goods. The Company’s products include Dispersible Kid Tablets for Pediatric patients; REKFA (...

Incorporated on

01 Nov 1988

Last Annual

Last Interim

No. of Employees

IPO date

20 Feb 1995

Free Float

15,41,139

Website

https://www.rekvinalaboratories.com/

Phone no.

Address

328 Paradise Complex, Sayajigunj, Baroda Varodara, VADODARA, 390005, India

Frequently Asked Questions

What is the current share price of Rekvina Laboratories Ltd.?

The current share price of Rekvina Laboratories Ltd. is ₹ 25.27 as of 24 Jul 2026.

What is the market capitalisation of Rekvina Laboratories Ltd.?

The market capitalisation of Rekvina Laboratories Ltd. stands at ₹ 15.23 Cr.

What is the PE ratio of Rekvina Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Rekvina Laboratories Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Rekvina Laboratories Ltd.?

Rekvina Laboratories Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.

What is the 52-week high and low of Rekvina Laboratories Ltd.?

The 52-week high of Rekvina Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Rekvina Laboratories Ltd.?

The dividend yield of Rekvina Laboratories Ltd. is - based on the current market price.

What is the FII and DII holding in Rekvina Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 52.21% of Rekvina Laboratories Ltd. shares.

What sector does Rekvina Laboratories Ltd. belong to?

Rekvina Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Rekvina Laboratories Ltd.?

The beta of Rekvina Laboratories Ltd. is -, indicating its price volatility relative to the broader market.

What is the RSI of Rekvina Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Rekvina Laboratories Ltd. is 17.46, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Rekvina Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Rekvina Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile